Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05161195
Title Roll-over Study to Allow Continued Access to Ribociclib
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

breast cancer

Therapies

Fulvestrant + Ribociclib

Ribociclib

Ribociclib + Tamoxifen

Goserelin + Ribociclib

Letrozole + Ribociclib

Anastrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers Recruiting Chandler Arizona 85224 United States Details
Highlands Oncology Group Recruiting Fayetteville Arkansas 72703 United States Details
Beverly Hills Cancer Center Recruiting Beverly Hills California 90211 United States Details
Poudre Valley Hospital Recruiting Fort Collins Colorado 80528 United States Details
Mid Florida Hematology and Oncology Center Recruiting Orange City Florida 32763 United States Details
Summit Cancer Care Recruiting Savannah Georgia 31405 United States Details
John D Archbold Memorial Hospital Recruiting Thomasville Georgia 31792 United States Details
Joliet Oncology-Hematology Associates Recruiting Joliet Illinois 60435 United States Details
Indiana University Health Goshen Center for Cancer Recruiting Goshen Indiana 46526 United States Details
Northern Light Mercy Hospital Recruiting Portland Maine 04102 United States Details
Englewood Health Recruiting Englewood New Jersey 07631 United States Details
The Valley Hospital / Luckow Pavillion Recruiting Paramus New Jersey 07652 United States Details
Eastchester Center for Cancer Care Recruiting Bronx New York 10469 United States Details
University Hospitals of Cleveland Seidman Cancer Center Recruiting Cleveland Ohio 44106 United States Details
Oklahoma Cancer Specialists and Research Institute Recruiting Tulsa Oklahoma 74136 United States Details
Millennium Research Clin Develop Recruiting Houston Texas 77090 United States Details
Novartis Investigative Site Recruiting Ijuí RS 98700-000 Brazil Details
Novartis Investigative Site Recruiting Sao Paulo SP 01317 000 Brazil Details
Novartis Investigative Site Recruiting São Paulo SP 03102 Brazil Details
Novartis Investigative Site Recruiting Hong Kong Hong Kong Details
Novartis Investigative Site Recruiting Shatin, New Territories Hong Kong Details
Novartis Investigative Site Recruiting Meldola FC 47014 Italy Details
Novartis Investigative Site Recruiting Osaka-city Osaka 540-0006 Japan Details
Novartis Investigative Site Recruiting Bunkyo ku Tokyo 113-8431 Japan Details
Novartis Investigative Site Recruiting Bunkyo ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Recruiting Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Recruiting Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Recruiting Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Recruiting Gdansk 80 952 Poland Details
Novartis Investigative Site Recruiting Singapore 119228 Singapore Details
Novartis Investigative Site Recruiting Sant Joan Despi Barcelona 08970 Spain Details
Novartis Investigative Site Recruiting Taipei 10041 Taiwan Details
Novartis Investigative Site Recruiting Taipei Taiwan Details
Novartis Investigative Site Recruiting Izmir 35040 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field